Results 21 to 30 of about 11,659 (226)
Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis
Annals of Clinical and Translational Neurology, 2022 Background Primary focal hyperhidrosis (PFH) is an autonomic neurological disease in which exocrine glands are oversecreted due to autonomic dysfunction of the sympathetic nervous system. Chrna1 promotes the pathogenesis of PFH.
Jian‐Bo Lin +3 more
doaj +1 more source
Dermatologica, 2009 A case of local hyperhidrosis at the ulnar aspect of the left forearm-carpal region with exacerbation, especially during summer, is presented. The sweat function is normal on the remainder of the body. This case is rare, and few similar cases are known in the literature. The possible pathogenetic mechanisms are discussed.
HATZIS, J +4 more
openaire +4 more sources
Hyperhidrosis post-treatment questionnaire.
, 2023 The use of reconstituted and frozen left-over botulinum toxin A, for treatment of patients with axillary hyperhidrosis seems to be common practice in healthcare.
Antonia Boman (17549613) +3 more
core +1 more source
Current treatment options for craniofacial hyperhidrosis [PDF]
Jornal Vascular Brasileiro, 2020 Hyperhidrosis (HH) is characterized by sweating exceeding the amount necessary to meet the thermal regulation and physiological needs of the body. Approximately 9.41% of individuals with HH have craniofacial hyperhidrosis (FH).
Nelson Wolosker +4 more
doaj +1 more source
, 2023 Hyperhidrosis is a non-fatal condition in which the patient would express excessive sweat. There are a lot of treatments already available including anticholinergic drugs which would inhibit the M3 human receptors.
Felicia, Austin +3 more
core +1 more source
Scientific Reports, 2021 Compensatory hyperhidrosis is the leading cause of patients' dissatisfaction after thoracic sympathicotomy. The study aimed to reduce compensatory hyperhidrosis to increase patients’ satisfaction.
Vicente Vanaclocha +6 more
doaj +1 more source
Clinical, Cosmetic and Investigational Dermatology, 2014 Primary hyperhidrosis (HH), a condition of sweating in excess of thermoregulatory requirements, affects nearly 3% of the US population and carries significant emotional and psychosocial implications. Unlike secondary HH, primary HH is not associated with an identifiable underlying pathology.
Stashak,Anna-Bianca, Brewer,Jerry D
openaire +4 more sources
Hyperhidrosis pre-treatment questionnaire.
, 2023 The use of reconstituted and frozen left-over botulinum toxin A, for treatment of patients with axillary hyperhidrosis seems to be common practice in healthcare.
Antonia Boman (17549613) +3 more
core +1 more source
Clinics, 2008 INTRODUCTION: Level T4 video-assisted thoracoscopic sympathectomy proved superior to T3-T4 treatment for controlling axillary hyperhidrosis at the initial and six-month follow-ups of these patients.
Marco Antonio S. Munia +4 more
doaj +1 more source
Evaluation of Extended Thoracoscopic Sympathectomy in the Treatment of Primary Palmar Hyperhidrosis [PDF]
Al-Azhar International Medical Journal, 2000 Background: Management of palmar and axillary hyperhidrosis is contingent upon the sympathetic denervation of the specific area afflicted, typically corresponding to the innervation provided by thoracic sympathetic ganglia numbers 2, 3, and 4.
Mahsoub Amin, Ahmed Daha, Ahmed Elgmal
doaj +1 more source